BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  UF-Led Alzheimer’s Research Center Awarded $22 Million to Accelerate Discoveries; Neuropacs CSO David Vaillancourt to Play Key Scientific Leadership Role

  September 29, 2026

   · 

  5 min read
• Press Releases

  NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies

  September 29, 2026

   · 

  3 min read
• Press Releases

  VectorY Expands PIONEER-ALS Phase 1/2 Clinical Trial Size

  September 29, 2026

   · 

  4 min read
• Press Releases

  Promega Launches Paradyme™ 27GY STR System, Minimizing Stutter Artifacts in Forensic DNA Analysis

  September 29, 2026

   · 

  4 min read
• Press Releases

  Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB

  September 29, 2026

   · 

  8 min read
• Press Releases

  Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis

  September 29, 2026

   · 

  10 min read
• Press Releases

  Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer

  September 29, 2026

   · 

  11 min read
• Press Releases

  Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia

  September 29, 2026

   · 

  5 min read
• Press Releases

  Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program

  September 29, 2026

   · 

  6 min read
• Press Releases

  NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs

  September 29, 2026

   · 

  6 min read